Evidence map›Paper›PMID 20610351›Full record

ReviewAdvances in chronic kidney disease2010

Health-related quality of life in hypertension, chronic kidney disease, and coexistent chronic health conditions.

Ritu K Soni, Anna C Porter, James P Lash, Mark L Unruh

Abstract readReview
In one paragraph

Review in Advances in chronic kidney disease, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it, 96 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Ritu K SoniDepartment of Medicine, University of Pittsburgh Medical Center, PA, USA.
Anna C Porter
James P Lash
Mark L Unruh
University of Pittsburgh Medical Center · US

Funding

Impact of Nocturnal Hemodialysis on Sleep Apnea, Sleep Quality & Daytime SymptomsR01DK077785 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI UNRUH, MARK LYNN · 2007 to 2011
$1.3M
Sleep and Daytime Functioning in Chronic Kidney DiseaseK23DK066006 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI UNRUH, MARK LYNN · 2004 to 2008
$710k
NIDDK NIH HHS DK66006NIDDK NIH HHS DK77785NIDDK NIH HHS K23 DK066006NIDDK NIH HHS R01 DK077785
6 · The paper itself

Abstract

With the increasing prevalence of hypertension, there has been a growing interest in understanding the health-related quality of life (HRQOL) of patients with hypertension. Although hypertension is often perceived as asymptomatic, it is associated with impaired HRQOL because of complications or comorbidities, awareness of the diagnosis, and adverse effects from antihypertensive medications. This article focuses on the literature published since 2000, on HRQOL in elderly hypertensive individuals as well as hypertensives with co-existent diseases, including chronic kidney disease, cardiovascular disease, and diabetes mellitus. Most of the studies found that hypertensive individuals with co-existent co-morbidities tend to have lower HRQOL than those with hypertension alone, and identified the number of co-morbid illnesses as an independent determinant of HRQOL. The most pronounced effect was noted in the physical function domains of HRQOL. Studies have also examined the effects on HRQOL of specific classes of antihypertensive drugs without specific demonstration of superiority of one drug class over another in terms of HRQOL measures. Although there is evidence in favor of angiotensin-converting enzyme-inhibition for improving renal and cardiovascular outcomes in hypertensive patients, its role in ameliorating HRQOL outcomes remains to be established.

Indexed as

Quality of LifeAgedAged, 80 and overCardiovascular DiseasesChronic DiseaseComorbidityDiabetes MellitusHumansHypertensionKidney Diseases

Identifiers

PMID20610351
PMCPMC2901238
OpenAlexW1973617126

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.